Mallinckrodt Hospital Products Inc. recalls Acthar Gel (repository…
Mallinckrodt Hospital Products Inc. recalls Acthar Gel (repository corticotropin injection)
- Published
- 2 Sept 2026
- Units affected
- 12367 vials
- Agency
- FDA
- Country
- United States
The hazard
Presence of particulate matter: glass and stopper piece
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2
- Brand / company
- Mallinckrodt Hospital Products Inc.
- Codes / lots
- Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027
- Distribution
- USA Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 2 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.